An economic study reveals wide-ranging costs in bringing new drugs to market, with pharmaceutical companies experiencing stable research and development (R&D) intensity, suggesting potential for reduced prices without compromising innovation.
A recent study found that current transvaginal ultrasonography triage strategies may not be useful for accurately diagnosing endometrial cancer among Black patients at risk for the malignancy.
The FDA has approved a new injectable treatment designed to simplify and enhance the administration of thiotepa, a drug used in the treatment of breast and ovarian cancers.
The U.S. Food and Drug Administration issued draft guidance for drugmakers and medical device makers to improve diversity in clinical trials, emphasizing the importance of actions to support more equitable access to medical innovations.
Judge rules in favor of AHA, declaring HHS's online tracking restrictions unlawful, impacting hospitals' use of web technologies for health information sharing.
Cyberattack on Ascension hospitals across the U.S. compromises patient care, leading to medication errors, delayed lab results, and patient safety risks, as health workers struggle without access to critical electronic systems.
A recent study reveals that surgeons are most frequently reported for unprofessional behavior by coworkers, while pediatric-focused physicians are least likely to be reported.
A call to action for the White House Initiative on Women's Health Research to prioritize critical research areas addressing the unique health needs of older women, who have been historically underrepresented in medical studies.